Who We Are

Healthium Medtech Limited is a global medtech company focused on products used in surgical, post-surgical and chronic care. Our vision is to provide "Access to precision medtech for every patient, globally."
We operate across three key markets, India, UK and Rest of the World and four focus areas: advanced surgery, wound care, urology and arthroscopy. One in five surgeries conducted globally uses a Healthium product as on 31st March, 2021.

As of Fiscal Year 2021, Healthium is:

  • The largest independent medical device company in India and second largest in the surgical consumables market in India.
  • The largest non-captive surgical needles manufacturer globally by volume.
  • The third-largest company in the urology collection devices market in the UK.

Our Evolution

Experienced Management Driving Growth Acceleration

Started operations in


  • Building on Global Quality

    Suture manufacturer with focus on quality

  • FY 2002

    EC certification for absorbable and non-absorbable sutures.

  • FY 2006

    Received 1st Letter of approval from US FDA.

  • Gearing for Growth

    Business expansion through acquisitions.

  • FY 2016

    Acquired Clinisupplies Ltd.

  • FY 2017

    Acquired QNPL.

  • FY 2017

    Acquired the 1st patent in the name of our Company

  • Acceleration

    Focus on integrating platform, expanding market access and diversifying portfolio

  • 2018

    New Management Team.

  • FY 2020

    Initiated clinical trials to comply with EU MDR 2021.

  • FY 2021

    Filed 50th patent application in the name of our Company.

  • FY 2022

    Acquired VitalCare.

    Acquired the Abgel Gelatin sponge Business.

    Acquired CareNow Medical.

Our Global Presence

We have business across three key markets namely
India, UK and Rest of the world

Healthium exports its range of products to over 80 countries, including developed markets such as the US, UK, Germany and France, and developing markets in South America, Asia and Africa.
Healthium has extensive presence in the UK with contracts with NHS and listing on the UK Drug Tariff. It delivers directly to patients through its dispensing appliance contractor license (“DAC license”)
Healthium has India’s largest direct sales force amongst independent medical device manufacturers which covers 90% of all districts in India with secondary healthcare facilities, with over 40,000 surgeons in over 18,000 hospitals as on 31st March 2021.


(formerly known as Healthium Medtech Private Limited)

472/D, 13th Cross, 4th Phase, Peenya Industrial Area, Peenya Industrial Area Phase IV, Peenya, Bengaluru, Karnataka - 560 058, INDIA

CIN: U03311KA1992PLC013831


For any queries or complaints write to

Customer care number


“Healthium Medtech Limited is proposing, subject to receipt of requisite approvals, market conditions and other considerations, to make an initial public offer of its equity shares and has filed a draft red herring prospectus (“DRHP”) with the Securities and Exchange Board of India. The DRHP is available on the website of the SEBI at www.sebi.gov.in as well as on the websites of the book running lead managers, ICICI Securities Limited, CLSA India Private Limited, Credit Suisse Securities (India) Private Limited and Nomura Financial Advisory and Securities (India) Private Limited, at www.icicisecurities.com, www.india.clsa.com, www.credit-suisse.com and www.nomuraholdings.com/company/group/asia/india/index.html, respectively, and the websites of the stock exchange(s) at www.bseindia.com and www.nseindia.com, respectively. Any potential investor should note that investment in equity shares involves a high degree of risk and for details relating to such risk, see "Risk Factors" of the RHP / Prospectus, when available. Potential investors should not rely on the DRHP for any investment decision.”

We use cookies to ensure you get the best experience on our website. Click here to view cookie policy